GlassScriptPhysician profile
Khaled Awad
NPI 1902335565
$623.39
in general payments reported to CMS, 2019-2025
11 companies · $245 in 2025
The $245 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $162 · 2023: $90.40 · 2024: $126 · 2025: $245.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $461.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $461.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $138.16 | 2025 | Watchman Flx |
| Abbott Laboratories | $131.68 | 2024-2025 | Aveir, Ensite |
| Pacira Therapeutics, INC. | $91.19 | 2019 | |
| Abbvie INC. | $90.40 | 2023 | Avycaz |
| Janssen Pharmaceuticals, INC | $65.97 | 2024 | Xarelto |
| Biosense Webster, INC. | $35.16 | 2025 | Carto 3 |
| Astrazeneca Pharmaceuticals LP | $16.58 | 2019 | |
| Philips North America LLC | $16.31 | 2019 | |
| Novartis Pharmaceuticals Corporation | $14.72 | 2019 | |
| Allergan, INC. | $12.27 | 2019 | |
| Pfizer INC. | $10.95 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Khaled Awad listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.